As of Feb 17
| -1.57 / -1.20%|
The 18 analysts offering 12-month price forecasts for Alexion Pharmaceuticals Inc have a median target of 171.50, with a high estimate of 217.00 and a low estimate of 120.00. The median estimate represents a +33.13% increase from the last price of 128.82.
The current consensus among 21 polled investment analysts is to Buy stock in Alexion Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.